RL-MT
Showing 26 - 50 of 1,177
Observatory of Pulmonary Arterial Hypertension of Congenital
Completed
- Pulmonary Arterial Hypertension of Congenital Heart Disease
-
Paris, FranceHopital Necker Enfants Malades
Sep 20, 2022
Peripheral T Cell Lymphoma (PTCL), Cell Therapy Trial in United States (MT-101, MT-101 + Conditioning (Lymphodepleting)
Recruiting
- Lymphoma, T-Cell, Peripheral
- +4 more
- MT-101
- MT-101 + Conditioning (Lymphodepleting) Chemotherapy
-
Duarte, California
- +8 more
Jan 27, 2023
Cognitive Impairment, Schizophrenia Trial in Long Beach (RL-007, RL-007 Matching Placebo)
Completed
- Cognitive Impairment
- Schizophrenia
- RL-007
- RL-007 Matching Placebo
-
Long Beach, CaliforniaCollaborative Neuroscience Research
Apr 25, 2022
Healthy Aging, Cognitive Impairment Trial in Derby (Music Therapy)
Recruiting
- Healthy Aging
- Cognitive Impairment
- Music Therapy
-
Derby, United KingdomMHA Methodist Homes
Aug 23, 2022
Acute Ischemic Stroke Trial in Munich (standardized MT alarming system)
Recruiting
- Acute Ischemic Stroke
- standardized MT alarming system
-
Munich, Bavaria, GermanyMunich Municipal Hospital
Jul 19, 2023
Stroke Rehabilitation Trial in Taichung, Taipei (Mirror therapy (MT) priming with task-specific training, Mirror therapy priming
Completed
- Stroke Rehabilitation
- Mirror therapy (MT) priming with task-specific training
- +2 more
-
Taichung, Taiwan
- +1 more
Aug 11, 2022
Epithelial Tumors, Malignant Trial in Randwick (MT-302 (A))
Recruiting
- Epithelial Tumors, Malignant
- MT-302 (A)
-
Randwick, New South Wales, AustraliaScientia Clinical Research Ltd
Aug 1, 2023
Erythropoietic Protoporphyria (EPP), X-Linked Protoporphyria (XLP) Trial in Worldwide (Dersimelagon, Placebo)
Not yet recruiting
- Erythropoietic Protoporphyria (EPP)
- X-Linked Protoporphyria (XLP)
- Dersimelagon
- Placebo
-
Huntington Beach, California
- +25 more
Nov 17, 2023
Osteitis Pubis, Athletic Pubalgia Trial in Soria (High force lateral distraction, Placebo distraction group)
Not yet recruiting
- Osteitis Pubis
- Athletic Pubalgia
- High force lateral distraction
- Placebo distraction group
-
Soria, SpainSilvia Lahuerta Martín
Feb 3, 2023
Acute Anterior or Posterior Cerebral Artery Occlusion
Completed
- Ischemic Stroke
- Thrombi
-
Paris, Ile-de-France, FranceHôpital Fondation Adolphe de Rothschild
Dec 9, 2022
Oral Antibiotic Bowel Preparation in Gynecologic Oncology
Active, not recruiting
- Surgical Site Infection
- +2 more
- Diagnosed with Surgical Site Infection
-
York, PennsylvaniaWellSpan
Jun 12, 2022
Opioid Use, Pain Trial (MORE, SMP, TAU)
Not yet recruiting
- Opioid Use
- Pain
- MORE
- +2 more
- (no location specified)
Sep 4, 2023
Osteitis Pubis Trial in Soria (High force hip Lateral distraction, Placebo force hip lateral distraction)
Not yet recruiting
- Osteitis Pubis
- High force hip Lateral distraction
- Placebo force hip lateral distraction
-
Soria, SpainSilvia Lahuerta Martín
Jan 25, 2023
Preterm Birth Trial in Worldwide (MT during NICU, MT after NICU, Standard care)
Completed
- Preterm Birth
- MT during NICU
- +2 more
-
Buenos Aires, Caba, Argentina
- +9 more
Nov 21, 2022
Non-specific Chronic Low Back Pain Trial in Thessaloníki (MT+ PNE with MI, MT, Control)
Active, not recruiting
- Non-specific Chronic Low Back Pain
- MT+ PNE with MI
- +2 more
-
Thessaloníki, Sindos Thessaloníki, Greece, GreeceDepartment of Physiotherapy, Faculty of Health Sciences Internat
Jun 23, 2023
Spinal Cord Injuries, Upper Extremity Paresis Trial in Dallas (Active Vagus Nerve Stimulation, Placebo Vagus Nerve Stimulation)
Recruiting
- Spinal Cord Injuries
- Upper Extremity Paresis
- Active Vagus Nerve Stimulation
- Placebo Vagus Nerve Stimulation
-
Dallas, TexasBaylor University Medical Center
Jan 4, 2023
Heart Valve Diseases Trial in Tehran (Six percent hydroxy ethyl starch 130/0.4, Ringer lactate)
Completed
- Heart Valve Diseases
- Six percent hydroxy ethyl starch 130/0.4
- Ringer lactate
-
Tehran, Iran, Islamic Republic ofRajaie CMRC
Jan 23, 2022
An Optimized Multi-Target Stool DNA Test, for Colorectal Cancer
Active, not recruiting
- Colorectal Cancer
- mt-sDNA 2.0 screening test
- +2 more
-
Birmingham, Alabama
- +191 more
Jan 9, 2023
Non-Hodgkin's B-cell Lymphoma, Leukemia, Lymphocytic, Chronic, B-Cell, Small Lymphocytic Leukemia Trial in Worldwide (MT-3724
Terminated
- Non-Hodgkin's B-cell Lymphoma
- +5 more
- MT-3724 Phase 1
- MT-3724 Phase 2
-
Tucson, Arizona
- +40 more
Jul 18, 2022
Stroke Trial in Hong Kong (Transcutaneous electrical nerve stimulation (TENS), Mirror Therapy (MT), sham-Mirror Therapy
Recruiting
- Stroke
- Transcutaneous electrical nerve stimulation (TENS)
- +3 more
-
Hong Kong, Hong KongThe Hong Kong Polytechnic University
Aug 2, 2022
Erythropoietic Protoporphyria (EPP) Trial in United States (MT-7117 low dose, MT-7117 high dose, Placebo)
Completed
- Erythropoietic Protoporphyria (EPP)
- MT-7117 low dose
- +2 more
-
Los Angeles, California
- +8 more
Dec 22, 2022
Acute Ischemic Stroke, Ischemic Stroke Trial in Iowa City (Tirofiban Hydrochloride, Placebo)
Withdrawn
- Acute Ischemic Stroke
- Ischemic Stroke
- Tirofiban Hydrochloride
- Placebo
-
Iowa City, IowaUniversity of Iowa Hospitals and Clinics
Sep 16, 2022
Chronic Lower Back Pain Trial in Rochester (Manual Therapy, Mind Body Intervention)
Completed
- Chronic Lower Back Pain
- Manual Therapy
- Mind Body Intervention
-
Rochester, New YorkRochester Outpatient Clinic
Mar 29, 2022
Healthy Adult Males Trial in Shinjuku-ku (MT-3921, Placebo)
Completed
- Healthy Adult Males
- MT-3921
- Placebo
-
Shinjuku-ku, Tokyo, JapanClinical Research Hospital Tokyo
Jan 16, 2023